AlenCiken

Biomerica’s Covid-19 Antigen Rapid Test Receives CE Mark

NASDAQ:BMRA   Biomerica, Inc
Biomerica’s Fast 15-Minute Simple to Use Covid-19 Antigen Rapid Test Receives CE Mark

Biomerica receives first orders and plans to ship tests in coming weeks

Clinical studies demonstrated an overall performance of 94.7% positive agreement (sensitivity) and 99.7% negative agreement (specificity) as compared to lab-based molecular PCR tests

The Company has already received its first European orders and plans to ship the first part of these orders in the coming weeks. The Company will now begin marketing this product broadly in Europe and other regions outside of the US.

merica’s new COVID-19 Antigen Rapid Test is highly portable, affordable , and provides results in 15 minutes with no equipment required to perform or read the test.

https://finance.yahoo.com/news/biomerica...

Comments